Mankind Pharma, NIIT, Torrent Power, Kajaria Ceramics, BPCL and TCS. 2 /13. Mankind Pharma Share Price Target Axis Direct has suggested buying the stock for a target of Rs 2,600. 3 /13. Mankind Pharma ...

Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Company to the eligible employees who have exercised their options pursuant to the ESOP Plan. Consequent to the ...

Mankind Pharma Background - Read about Mankind Pharma, its background on The Economic Times. Benchmarks . Nifty 24,750.70-82.9. FEATURED FUNDS ...

Arora’s vision is to see Mankind Pharma as India’s No. 1 domestic pharma company in the coming few years. The growth, he said, will come largely from three-four areas. First being the BSV portfolio, ...

In FY25, Mankind signed a non-exclusive patent licensing agreement with Takeda Pharmaceuticals to commercialise its novel drug Vonoprazan, to treat Gastroesophageal Reflux Disease (GERD).

Mankind Pharma has given-15.55% in this year & -5.45% in the last 5 days. Mankind Pharma has TTM P/E ratio 49.03 as compared to the sector P/E of 25.20 . There are 15 analysts who have initiated ...